Clinical application of belimumab in lupus nephritis
As a human monoclonal antibody specific for B lymphocyte stimulator （BLyS）， belimumab has recently become the first drug approved by the US Food and Drug Administration （FDA） for managing adult active lupus nephritis （LN）. LN affects up to 60% of patients with systemic lupus erythematosus （SLE） and...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Chinês |
| Gepubliceerd in: |
Editorial Department of Journal of Clinical Nephrology
2022-10-01
|
| Reeks: | Linchuang shenzangbing zazhi |
| Onderwerpen: | |
| Online toegang: | http://www.lcszb.com/thesisDetails#10.3969/j.issn.1671-2390.2022.10.011 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|